Thinking of joining a study?

Register your interest

NCT05591859 | RECRUITING | Arthropathy


Restoration Anatomic Acetabular Shell Revision Study
Sponsor:

Stryker Orthopaedics

Brief Summary:

This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjects who meet the eligibility criteria.

Condition or disease

Arthropathy

Hip Arthropathy

Hip Osteoarthritis

Intervention/treatment

Restoration Anatomic Acetabular Shell

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 56 participants
Masking : NONE
Primary Purpose : TREATMENT
Official Title : Restoration Anatomic Acetabular Shell Revision Study - A Post-market, Multi-center Evaluation of the Clinical Outcomes of the Restoration Anatomic Acetabular Shell in a Revision Indication
Actual Study Start Date : 2024-03-02
Estimated Primary Completion Date : 2036-03-01
Estimated Study Completion Date : 2036-03-01

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Subject is a candidate for a revision of a failed acetabular component with the Restoration Anatomic Acetabular Shell.
  • * Subject has signed an IRB-approved, study specific Informed Consent Form (ICF).
  • * Subject is skeletally mature.
  • * Subject is a male or non-pregnant female.
  • * Subject is willing and able to comply with postoperative scheduled clinical evaluations.
Exclusion Criteria
  • * Subject has a non-Stryker retained stem at the time of study device implantation.
  • * Subject has a Body Mass Index (BMI) \> 45.
  • * Subject has an active or suspected latent infection in or about the affected hip joint at time of study device implantation.
  • * Subject has a mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure, or complications in postoperative care.
  • * Subject has compromised bone stock which cannot provide adequate support and/or fixation to the prosthesis.
  • * Subject is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.
  • * Subject is immunologically suppressed or receiving steroids in an excess of normal physiological requirements (e.g. \> 30 days).
  • * Subject has a known sensitivity to device materials.
  • * Subject is a prisoner.

Restoration Anatomic Acetabular Shell Revision Study

Location Details

NCT05591859


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

United States, Colorado

Regents of the University of Colorado

Denver, Colorado, United States, 80045

Loading...